196 related articles for article (PubMed ID: 33111480)
21. Improving decision making in multidisciplinary tumor boards: prospective longitudinal evaluation of a multicomponent intervention for 1,421 patients.
Lamb BW; Green JS; Benn J; Brown KF; Vincent CA; Sevdalis N
J Am Coll Surg; 2013 Sep; 217(3):412-20. PubMed ID: 23891067
[TBL] [Abstract][Full Text] [Related]
22. Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors.
Sotelo-Rodríguez C; Vallejo-Ardila D; Ruiz-Patiño A; Chamorro DF; Rodríguez J; Moreno-Pérez DA; Carranza H; Otero J; Vargas C; Archila P; Rojas L; Zuluaga J; Rubio C; Ordóñez-Reyes C; Garcia-Robledo JE; Mejía S; Jaller E; Arrieta O; Cardona AF
JCO Glob Oncol; 2024 Jan; 10():e2300011. PubMed ID: 38237094
[TBL] [Abstract][Full Text] [Related]
23. Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center.
Tögel L; Schubart C; Lettmaier S; Neufert C; Hoyer J; Wolff K; Moskalev EA; Stöhr R; Agaimy A; Reis A; Wullich B; Mackensen A; Pavel M; Beckmann MW; Hartmann A; Fietkau R; Meidenbauer N; Haller F; Spoerl S
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136436
[TBL] [Abstract][Full Text] [Related]
24. Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer.
Gebbia V; Guarini A; Piazza D; Bertani A; Spada M; Verderame F; Sergi C; Potenza E; Fazio I; Blasi L; La Sala A; Mortillaro G; Roz E; Marchese R; Chiarenza M; Soto-Parra H; Valerio MR; Agneta G; Amato C; Lipari H; Baldari S; Ferraù F; Di Grazia A; Mancuso G; Rizzo S; Firenze A
Pulm Ther; 2021 Dec; 7(2):295-308. PubMed ID: 34089169
[TBL] [Abstract][Full Text] [Related]
25. Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting.
VanderWalde A; Grothey A; Vaena D; Vidal G; ElNaggar A; Bufalino G; Schwartzberg L
J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33260805
[TBL] [Abstract][Full Text] [Related]
26. A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence.
Sunami K; Naito Y; Saigusa Y; Amano T; Ennishi D; Imai M; Kage H; Kanai M; Kenmotsu H; Komine K; Koyama T; Maeda T; Morita S; Sakai D; Hirata M; Ito M; Kozuki T; Sakashita H; Horinouchi H; Okuma Y; Takashima A; Kubo T; Hironaka S; Segawa Y; Yakushijin Y; Bando H; Makiyama A; Suzuki T; Kinoshita I; Kohsaka S; Ohe Y; Ishioka C; Yamamoto K; Tsuchihara K; Yoshino T
JAMA Oncol; 2024 Jan; 10(1):95-102. PubMed ID: 38032680
[TBL] [Abstract][Full Text] [Related]
27. Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India.
Mathew A; Davis S; Boby JM; R I A; Suryavanshi M; Dawood SS; Panda PK; Nag SM; Das A; Rohatgi N; Popat S; Shah RNH; Thampy C; Parikh AR; Yadav S; Mehta P; Singh R; Mukherji D; Shilpakar R; Mullapally SK; Sirohi B
JCO Glob Oncol; 2024 Mar; 10():e2300330. PubMed ID: 38484196
[TBL] [Abstract][Full Text] [Related]
28. Implementing multidisciplinary tumor boards in oncology: a narrative review.
Mano MS; Çitaku FT; Barach P
Future Oncol; 2022 Jan; 18(3):375-384. PubMed ID: 34787482
[TBL] [Abstract][Full Text] [Related]
29. Extending cBioPortal for Therapy Recommendation Documentation in Molecular Tumor Boards: Development and Usability Study.
Renner C; Reimer N; Christoph J; Busch H; Metzger P; Boerries M; Ustjanzew A; Boehm D; Unberath P
JMIR Med Inform; 2023 Dec; 11():e50017. PubMed ID: 38079196
[TBL] [Abstract][Full Text] [Related]
30. Challenges and Experiences Extending the cBioPortal for Cancer Genomics to a Molecular Tumor Board Platform.
Reimer N; Unberath P; Busch H; Börries M; Metzger P; Ustjanzew A; Renner C; Prokosch HU; Christoph J
Stud Health Technol Inform; 2021 Nov; 287():139-143. PubMed ID: 34795098
[TBL] [Abstract][Full Text] [Related]
31. The Impact of a Multidisciplinary Tumor Board (MTB) on Treatment Decision Making for Patients With Renal Cell Carcinoma (RCC): 5-Year Data Analysis.
Brink LVD; Ruiter AEC; Lagerveld BW; Graafland NM; Bex A; Beerlage HP; van Moorselaar JRA; Zondervan PJ
Clin Genitourin Cancer; 2024 Apr; 22(2):610-617.e1. PubMed ID: 38402089
[TBL] [Abstract][Full Text] [Related]
32. Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer.
Krause A; Stocker G; Gockel I; Seehofer D; Hoffmeister A; Bläker H; Denecke T; Kluge R; Lordick F; Knödler M
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1231-1240. PubMed ID: 35394231
[TBL] [Abstract][Full Text] [Related]
33. Clinician Perspectives Regarding the Impact of Information Technology on Multidisciplinary Tumor Boards: A National Comprehensive Cancer Network Survey.
Arafat W; Fu P; Wagner AJ; Osterman T; Martin DB; Sugalski J; Heinrichs T; Racz J; Tevaarwerk AJ
JCO Clin Cancer Inform; 2023 Sep; 7():e2300056. PubMed ID: 37944060
[TBL] [Abstract][Full Text] [Related]
34. Implementation and Outcomes of a Molecular Tumor Board at Herbert-Herman Cancer Center, Sparrow Hospital.
Trivedi H; Acharya D; Chamarthy U; Meunier J; Ali-Ahmad H; Hamdan M; Herman J; Srkalovic G
Acta Med Acad; 2019 Apr; 48(1):105-115. PubMed ID: 31264438
[TBL] [Abstract][Full Text] [Related]
35. Molecular Tumor Boards in Clinical Practice.
Luchini C; Lawlor RT; Milella M; Scarpa A
Trends Cancer; 2020 Sep; 6(9):738-744. PubMed ID: 32517959
[TBL] [Abstract][Full Text] [Related]
36. The value of virtual molecular tumor boards for informed clinical decision-making.
Angel M; Demiray M; Dişel U; Passos J
Oncologist; 2024 May; ():. PubMed ID: 38761380
[TBL] [Abstract][Full Text] [Related]
37. Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing.
Patel NM; Michelini VV; Snell JM; Balu S; Hoyle AP; Parker JS; Hayward MC; Eberhard DA; Salazar AH; McNeillie P; Xu J; Huettner CS; Koyama T; Utro F; Rhrissorrakrai K; Norel R; Bilal E; Royyuru A; Parida L; Earp HS; Grilley-Olson JE; Hayes DN; Harvey SJ; Sharpless NE; Kim WY
Oncologist; 2018 Feb; 23(2):179-185. PubMed ID: 29158372
[TBL] [Abstract][Full Text] [Related]
38. Genomic expertise in action: molecular tumour boards and decision-making in precision oncology.
Bourret P; Cambrosio A
Sociol Health Illn; 2019 Nov; 41(8):1568-1584. PubMed ID: 31197873
[TBL] [Abstract][Full Text] [Related]
39. Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices.
Rao S; Pitel B; Wagner AH; Boca SM; McCoy M; King I; Gupta S; Park BH; Warner JL; Chen J; Rogan PK; Chakravarty D; Griffith M; Griffith OL; Madhavan S
JCO Clin Cancer Inform; 2020 Jul; 4():602-613. PubMed ID: 32644817
[TBL] [Abstract][Full Text] [Related]
40. Molecular Tumor Board-Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial.
Miller RW; Hutchcraft ML; Weiss HL; Wu J; Wang C; Liu J; Jayswal R; Buchanan M; Anderson A; Allison DB; El Khouli RH; Patel RA; Villano JL; Arnold SM; Kolesar JM
JCO Precis Oncol; 2022 Aug; 6():e2100524. PubMed ID: 36103643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
